How can proteomics elucidate the complexity of multiple sclerosis?

Publisher： John Wiley & Sons Inc

E-ISSN： 1862-8354|1862-8346|9-10|844-847

ISSN： 1862-8346

Source： PROTEOMICS - CLINICAL APPLICATIONS, Vol.1862-8346, Iss.9-10, 2015-10, pp. : 844-847

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

How can proteomics elucidate the complexity of multiple sclerosis?

By  

PROTEOMICS - CLINICAL APPLICATIONS, Vol. 9, Iss. 9-10, 2015-10 ,pp. : 844-847

John Wiley & Sons Inc

Access to resources Recommend Favorite

Proteomics of a conundrum: Thoughts on addressing the aetiology versus progression of multiple sclerosis

By  

PROTEOMICS - CLINICAL APPLICATIONS, Vol. 9, Iss. 9-10, 2015-10 ,pp. : 838-843

John Wiley & Sons Inc

Access to resources Recommend Favorite

Proteomics of a conundrum: Thoughts on addressing the aetiology versus progression of multiple sclerosis

By  

PROTEOMICS - CLINICAL APPLICATIONS, Vol. 1862-8346, Iss. 9-10, 2015-10 ,pp. : 838-843

John Wiley & Sons Inc

Access to resources Recommend Favorite

Quantitative proteomics suggests decrease in the secretogranin‐1 cerebrospinal fluid levels during the disease course of multiple sclerosis

By  

PROTEOMICS, Vol. 1615-9853, Iss. 19, 2015-10 ,pp. : 3361-3369

John Wiley & Sons Inc

Access to resources Recommend Favorite

Quantitative proteomics suggests decrease in the secretogranin‐1 cerebrospinal fluid levels during the disease course of multiple sclerosis

By  

PROTEOMICS, Vol. 15, Iss. 19, 2015-10 ,pp. : 3361-3369

John Wiley & Sons Inc

Access to resources Recommend Favorite